Skip to content

Clinical trials

Completed Cognitive Dysfunction trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Status: Completed Country / region: Australia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20052
20072
20101
20131
20153
20172
20181
20215
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actinogen Medical3
The University of Queensland2
AbbVie1
Bayside Health1
Cognition Therapeutics1
CuraSen Therapeutics, Inc.1
Debiopharm International SA1
Eisai Limited1
Eli Lilly and Company1
Inmune Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction25
Alzheimer Disease10
Dementia9
Tauopathies3
Anxiety Disorders2
Memory Disorders2
Nervous System Diseases2
Neurodegenerative Diseases2
Pick Disease of the Brain2
Sleep Wake Disorders2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.